v3.26.3
Debt (Details Narrative)
9 Months Ended
Aug. 02, 2026
USD ($)
$ / shares
shares
Oct. 22, 2025
USD ($)
$ / shares
shares
Sep. 30, 2026
USD ($)
$ / shares
shares
Sep. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
shares
Short-Term Debt [Line Items]          
Principal amount $ 2,500        
Cash 2,050        
Discount amount $ 450,000        
Simple interest percent 18.00%        
Debt conversion description Conversion is subject to a 9.99% beneficial ownership limitation and to Nasdaq share-issuance limits. The Company may prepay the Notes at any time at 100% of principal without premium. In addition, 33% of the proceeds received under the Forward Purchase Agreement, and 33% of the net proceeds of any financing transaction, must be applied to repay the Notes at 100% of face value (the “mandatory prepayment”).        
Purchase of shares price     $ 2,050    
Proceeds from transaction cost     $ 1,714,140    
Financing receivable percent     83.60%    
Debt instrumental principal amount     $ 2,500,000    
Credit yield percent     410.30%    
Transaction costs     $ 150,000    
Line of credit facility description     They were allocated between the Notes and the Financing Warrants on the same relative fair value basis: $125.42 thousand to the Notes and $24.58 thousand to the Financing Warrants.    
Incremental fair value     $ (91,000) $ 1,405,000  
Effective interest rate     410.30%    
Amortization of convertible note discount     $ 294,000  
Repayments of Notes Payable     224,000  
Convertible Notes Payable, Current     1,245,000  
Converted shares | shares   8,048,770      
Related party note payable     $ 300,000   $ 300,000
Common stock warrants outstanding purchase shares | shares     18,931,612   16,375,911
Common stock warrant liability     $ 29,600   $ 121,000.0
Related party loan payable     $ 300,000   $ 300,000
Common Stock Warrants [Member]          
Short-Term Debt [Line Items]          
Common stock warrants outstanding purchase shares | shares     92,211   92,211
Common stock exercise price | $ / shares     $ 0.70    
Contractual term     10 years    
Second Warrant Amendment [Member]          
Short-Term Debt [Line Items]          
Common stock exercise price | $ / shares $ 10.00        
Incremental fair value $ 494,050.00        
Financing warrants issued description this cost was allocated between the Notes and the Financing Warrants on the same relative fair value basis: $413.11 thousand (83.6%) to the Notes, which is recorded as a debt discount against the carrying amount of the Notes (ASC 835-30) and amortized to interest expense over the term using the effective interest method, and $80.94 thousand (16.4%) to the Financing Warrants, which is recorded as a reduction of additional paid-in capital. Accordingly, the amendment resulted in a net increase of $413.11 thousand in additional paid-in capital, comprising a credit of $494.05 thousand presented as “Shortfall warrant amendment” and a reduction of $80.94 thousand presented within “Warrants issued in connection with new Convertible Notes”        
Warrant to purchase | shares 2,108,070        
Common stock exercise price | $ / shares $ 0.85        
Measurement Input, Share Price [Member]          
Short-Term Debt [Line Items]          
Warrant liability, measurement input 0.78   0.52   1.65
Measurement Input, Annualized Volatility [Member]          
Short-Term Debt [Line Items]          
Warrant liability, measurement input 65   65.0   62.0
Measurement Input, Risk Free Interest Rate [Member]          
Short-Term Debt [Line Items]          
Warrant liability, measurement input 4.4   4.94   3.99
Warrant [Member]          
Short-Term Debt [Line Items]          
Purchase of shares price $ 2,050,000        
Proceeds from transaction cost     $ 335,860    
Financing receivable percent     16.40%    
Common Stock [Member]          
Short-Term Debt [Line Items]          
Principal amount   $ 3,978,000      
Cash   $ 2,343,000      
August 2026 Convertible Promissory Notes Agreement [Member]          
Short-Term Debt [Line Items]          
Debt instrumental conversion price | $ / shares $ 4.20        
August 2026 Convertible Note [Member] | Common Stock [Member]          
Short-Term Debt [Line Items]          
Common stock exercise price | $ / shares $ 4.20   $ 4.20    
September 2024 Convertible Note [Member] | Common Stock [Member]          
Short-Term Debt [Line Items]          
Common stock exercise price | $ / shares   $ 11.50      
Warrant to purchase | shares   7,500